Sperginn® and Miocystinn® Fertile-powerful duo in fight against infertility

The problem of conception is, unfortunately, an increasingly common challenge that couples face today. Infertility is the inability of a sexually active, non-contracepting couple to achieve pregnancy in one year. Official figures say that 15% of couples have this problem. It is important to detect as early as possible that there are certain difficulties [...]

By |April 16th, 2021|Categories: News|0 Comments

Triple protection from infection over the course of 24h-Imunitinn®MR

Current epidemiological situation and daily stastics about number of people infected with virus COVID-19 have raised awareness when it comes to prevention. Choosing right product that will prevent the occurance of respiratory infections and and alleviate the symptoms if the disease has already developed clinically, is of big importance. An ideal product should contain [...]

By |April 15th, 2021|Categories: News|0 Comments

New markets

Innventa Pharm is significantly growing every year which further motivates us to offer inventive pharmaceutical solutions on new markets. We are successfully distributing our products on the markets of Serbia, Bosnia and Herzegovina, Montenegro and Albania, and starting from April, the complete Innventa portfolio will be available on the market of Northern Macedonia. "I [...]

By |April 15th, 2021|Categories: News|0 Comments

Nattokinn® and COVID-19 infection

Clinical studies have proven a connection between COVID-19 infection and increased blood clotting, which results in injury to the wall of blood vessels, favour the formation of the blood clots and the appearance of serious complications of the disease. According to the latest research, almost a third of patients with COVID-19 infection have high [...]

By |April 2nd, 2021|Categories: News|0 Comments

NITROFINN® – Important additional strenght to Innventa portfolio

NITROFINN® - Important additional strenght to Innventa portfolio After launching of Serapinn forte®, Forticolinn®, Miocytinn®, Laringinn® and Rhinosinn®, Innventa is continuing with fulfillment of ambitious 2018 new products launch plan. On 20th of July 2018 in Serbian pharmacies  is available new product in Innventa urology portfolio - Nitrofinn®. Nitrofinn® is currently the only registered Nitrofurantoin [...]

By |August 1st, 2018|Categories: News|0 Comments

Innventa Pharm on FASUS

At the Hyat Regency Hotel, on March 9, 2018, in the organization of BB Soft, XXIX Pharmaceutical Meeting FASUS was held. A large number of pharmacists, health technicians, wholesalers and pharmaceutical companies are gathered. More than 500 exhibitors, participants and visitors had the opportunity to exchange knowledge and experiences in the field of pharmacy. At [...]

By |March 16th, 2018|Categories: News|Tags: , , , , , , |0 Comments